| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/03/2010 | EP2148688A1 Treatment of infections by carbon monoxide |
| 02/03/2010 | EP2148671A1 Use of fungicides for treating fish mycoses |
| 02/03/2010 | EP2148664A1 Use of antivirals in the treatment of medical disorders |
| 02/03/2010 | EP1511742B1 Kinase inhibitors |
| 02/03/2010 | CN101637624A Medical devices containing rapamycin analogs |
| 02/03/2010 | CN100586297C Composition against periodontal bacteria |
| 02/02/2010 | US7655795 (3R,4R)-1-[(9-deazahypoxanthin-9-yl)methyl]-3-hydroxy-4-hydroxymethyl-pyrrolidine; reaction of formaldehydewith a cyclic amine and a heteroaromatic compound to give methylene linked cyclic amine deazapurines; cancer, bacterial, protozoal infections or T-cell mediated diseases |
| 02/02/2010 | US7655759 Recombinant bivalent monospecific immunoglobulin having at least two variable fragments of heavy chains of an immunoglobulin devoid of light chains |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655629 Peptides and their use for the treatment of HIV infections |
| 02/02/2010 | US7655624 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 02/02/2010 | US7655623 Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same |
| 02/02/2010 | US7655621 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/02/2010 | US7655427 Immunogenic proteins of Leptospira |
| 02/02/2010 | US7655425 Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES |
| 02/02/2010 | US7655412 Useful to form complexes having an affinity to targets of interest; verotoxin subunit B |
| 02/02/2010 | US7655248 Compositions and methods for treatment of candidiasis |
| 02/02/2010 | US7655246 Chlamydia protein, gene sequence and uses thereof |
| 02/02/2010 | US7655242 Defensin-inducing agents |
| 02/02/2010 | CA2585164C Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses |
| 02/02/2010 | CA2494583C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/02/2010 | CA2430562C Dna methyl transferase inhibitors |
| 02/02/2010 | CA2424186C Antimicrobial compositions formulated for use in cold temperature conditions and methods of use thereof |
| 02/02/2010 | CA2321819C Xylitol compositions for treating upper respiratory conditions |
| 02/02/2010 | CA2311942C An antimicrobial composition |
| 02/02/2010 | CA2230885C Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 02/02/2010 | CA2142331C Immunoglobulins devoid of light chains |
| 01/28/2010 | WO2010011975A1 Oxymatrine compositions and use thereof for treating and preventing chronic infectious diseases |
| 01/28/2010 | WO2010011959A1 Antiviral compounds |
| 01/28/2010 | WO2010011845A2 Methods of preventing or treating viral infection or reactivation after latency in a host using inhibitors of the lsd1 protein |
| 01/28/2010 | WO2010011622A2 Ophthalmic gallium compositions and methods of their use |
| 01/28/2010 | WO2010011611A2 Antimicrobially-primed medicinal maggot therapy |
| 01/28/2010 | WO2010011609A2 Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| 01/28/2010 | WO2010011566A1 Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors |
| 01/28/2010 | WO2010011347A2 Clip inhibitors and methods of modulating immune function |
| 01/28/2010 | WO2010011343A2 Methods for treating viral disorders |
| 01/28/2010 | WO2010011315A2 Proteins for use in diagnosing and treating infection and disease |
| 01/28/2010 | WO2010010948A1 Protection against norovirus infection or removal of norovirus by using substance associated with blood type |
| 01/28/2010 | WO2010010172A2 Glycolipid fraction from cyanobacteria for treatment of diseases of the oral cavity |
| 01/28/2010 | WO2010010149A1 Styrylquinolines, their process of preparation and their therapeutic uses |
| 01/28/2010 | WO2010010148A1 Styrylquinolines, their process of preparation and their therapeutic uses |
| 01/28/2010 | WO2010010147A1 Styrylquinolines, their process of preparation and their therapeutic uses |
| 01/28/2010 | WO2010010112A2 Construct and method for the internalization of cargo molecules into a cell |
| 01/28/2010 | WO2010010017A1 Heterocyclic antiviral compounds |
| 01/28/2010 | WO2010009762A1 Interferon and an agent inducing inhibition of protein phosphatase 2a such as interleukin- 1 and optionally ribavirin for the treatment of hbv or hcv infection |
| 01/28/2010 | WO2010009572A1 New low side effect pharmaceutical composition containing isoniazid |
| 01/28/2010 | WO2010009535A1 A method for inhibiting poxvirus infection and pathogenesis using the alkaloid berberine |
| 01/28/2010 | WO2009147075A3 Pharmaceutical compositions containing a crystalline form of posaconazole |
| 01/28/2010 | WO2009134856A3 Pharmaceutical gallium compounds, composition and methods of preparation |
| 01/28/2010 | WO2009106019A3 Chemical compounds having antiviral activity against dengue virus and other flaviviruses |
| 01/28/2010 | WO2009077497A3 Azolyl methyl oxiranes, the use thereof, and agents containing them |
| 01/28/2010 | US20100022652 Antimicrobial and Anticoagulant Compositions and Methods |
| 01/28/2010 | US20100022587 Derivatives of 2-phenyl-3-hydroxyquinoline-4(1h)-one and methods of their preparation and utilization |
| 01/28/2010 | US20100022578 Macrocyclic inhibitors of hepatitis c virus |
| 01/28/2010 | US20100022575 Oxymatrine compositions and related methods for treating and preventing chronic infectious diseases |
| 01/28/2010 | US20100022540 Triazole derivatives ii |
| 01/28/2010 | US20100022527 Biphenyl substituted spirotetronic acids and their use for the treatment of retroviral diseases |
| 01/28/2010 | US20100022524 Tricyclic tetrahydroquinoline antibacterial agents |
| 01/28/2010 | US20100022522 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 01/28/2010 | US20100022509 Inhibitors of MshC and Homologs Thereof, and Methods of Identifying Same |
| 01/28/2010 | US20100022508 Antiviral compounds |
| 01/28/2010 | US20100022504 Methods for treating latent tuberculosis |
| 01/28/2010 | US20100022483 Substituted Tetracycline Compounds |
| 01/28/2010 | US20100022468 Nucleoside cyclic phosphoramidates for the treatment of rna-dependent rna viral infection |
| 01/28/2010 | US20100022016 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 01/28/2010 | US20100021888 Screening for disease susceptibility by genotyping the CCR5 and CCR2 genes |
| 01/28/2010 | US20100021576 Bacillus Amyloliquefaciens K317 for Suppressing the Growth of Antibiotics-Resistant Pathogenic Microorganism or Enteropathogenic Microorganism |
| 01/28/2010 | US20100021563 Compositions comprising coconut oil and methods of use thereof |
| 01/28/2010 | US20100021562 Self preserved aqueous pharmaceutical compositions |
| 01/28/2010 | US20100021561 Self-preserved aqueous pharmaceutical compositions |
| 01/28/2010 | US20100021556 Method for the Production of an Agent Against an Infectious Disease |
| 01/28/2010 | US20100021552 Polysaccharide nanofibers having antimicrobial properties |
| 01/28/2010 | US20100021512 Incontinence garments with a silver lining infection stopper |
| 01/28/2010 | US20100021501 Live vaccine strains of francisella |
| 01/28/2010 | US20100021500 Processes for treating subjects carrying viral infectious agent |
| 01/28/2010 | US20100021497 Ipv-dpt vaccine |
| 01/28/2010 | US20100021491 PROTEIN KINASE DEFICIENT, IMMUNOLOGICALLY ACTIVE CMVpp65 MUTANT CELLULAR VACCINES |
| 01/28/2010 | US20100021489 comprising an RNA sequence capable of specifically binding a polypeptide participating in influenza virus infection of cells |
| 01/28/2010 | US20100021470 Monoclonal antibody production by ebv transformation of b cells |
| 01/28/2010 | US20100021469 Functional role of adrenomedullin (am) and the gene related product (pamp) in human pathology and physiology |
| 01/28/2010 | US20100021459 Polypeptide constructs for intracellular delivery |
| 01/28/2010 | US20100021458 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/28/2010 | US20100021453 Targeting of triacylclycerol synthase gene for tuberculosis treatment |
| 01/28/2010 | US20100021427 Use of Antiviral Peptides For Treatment of Infections Caused by Drug-Resistant HIV |
| 01/28/2010 | US20100021426 Methods for making and compositions comprising fermentation products of cordyceps sinensis |
| 01/28/2010 | US20100021425 1'-substituted carba-nucleoside analogs for antiviral treatment |
| 01/28/2010 | US20100021394 High penetration prodrug compositions of 1h-imidazo[4,5-c]quinolin-4-amines and 1h-imidazo[4,5-c]quinolin-4-amine-related compounds |
| 01/28/2010 | CA2737146A1 Clip inhibitors and methods of modulating immune function |
| 01/28/2010 | CA2737144A1 Methods for treating viral disorders |
| 01/28/2010 | CA2736842A1 Proteins for use in diagnosing and treating infection and disease |
| 01/28/2010 | CA2733218A1 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 01/28/2010 | CA2731842A1 Compositions and methods for the treatment of hepatitis c |
| 01/28/2010 | CA2731766A1 Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
| 01/28/2010 | CA2731686A1 Neutralizing anti-influenza a virus antibodies and uses thereof |
| 01/28/2010 | CA2731500A1 Glycolipid fraction from cyanobacteria for treatment of diseases of the oral cavity |
| 01/28/2010 | CA2731177A1 Macrocyclic quinoxaline compounds as hcv ns3 protease inhibitors |
| 01/28/2010 | CA2730517A1 Heterocyclic antiviral compounds |
| 01/27/2010 | EP2147925A1 Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 01/27/2010 | EP2147913A1 Styrylquinolines, their process of preparation and their therapeutic uses |
| 01/27/2010 | EP2147912A1 Styrylquinolines, their process of preparation and their therapeutic uses |